[ Price : $8.95]
CDER director Patrizia Cavazzoni says the 2023 Drug Safety Priorities report focuses on the nations drug overdose crisis.[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America asks FDA to take some specific follow-up steps to its virtual meeting on adva...[ Price : $8.95]
FDA increases its educational outreach to decrease hesitancy with biosimilar usage.[ Price : $8.95]
FDA grants Mesoblast an orphan-drug designation for Revascor (rexlemestrocel-L) and its use in children with congenital heart cond...[ Price : $8.95]
A Regulatory Affairs Professionals Society online post says FDA is several weeks late in delivering a congressionally mandated gui...[ Price : $8.95]
Harvard Medical School professor Peter Cohen blasts FDA for a lack of sufficient action to remove harmful dietary supplements from...[ Price : $8.95]
FDA denies a Zydus petition asking the action to take actions about the indomethacin suppository reference standard.[ Price : $8.95]
FDA releases the form FDA-483 with nine observations from an inspection at Indias Eugia Pharma Specialties sterile drug manufactur...